Articles in News
TargaZyme, Inc. Appoints Christopher Calhoun to Business Advisory Board
Pedal the Cause, San Diego announced five research projects funded by the net proceeds from the inaugural 2013 event at a press conference held at our La Jolla campus on May 29. Sanford-Burnham’s Michael Jackson, Ph.D., vice president of Drug Discovery and Development, and Robert Wechsler-Reya, Ph.D., director of the Tumor Initiation and Maintenance Program, each
Test looks for BRCA mutations, associated with breast, ovarian and other cancers.
San Diego biotech Celladon Corp. has appointed industry veteran Paul Cleveland as its new president and chief financial officer.
This past spring, students from The Benjamin School in North Palm Beach, Florida selected Sanford-Burnham as the recipient of funds raised as part of a philanthropy education program run by Main Street Philanthropy, an independent organization with the mission to inspire future generations to become passionate philanthropists. Main Street Philanthropy’s goal is to create dynamic,
The finding from the Burton lab is likely to influence future designs for HIV vaccines and antibody-based therapies.
The findings from the Buxbaum lab point to new approach to Alzheimer’s prevention and therapy.
A team from the Lazzerini Denchi lab shows a path to DNA damage that provides fertile ground for cancer.